Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Royal Numico/Rexall

This article was originally published in The Tan Sheet

Executive Summary

Firms settle class action litigation with shareholders seeking to enjoin Rexall directors from proceeding with the merger (1"The Tan Sheet" May 8, pp. 3-4). The agreement calls for the firms to lower the maximum fee and expenses reimbursement payable by Rexall to Royal Numico in the event the merger falls through to $60 mil. from $79 mil., provide Rexall shareholders with appraisal rights related to the merger and confirm to stockholders the absence of any inquiries by third parties concerning possibly buying Rexall. Numico and Rexall have denied wrongdoing in the case, saying they entered into the settlement to avoid the expense and distraction of continued litigation

You may also be interested in...

Royal Numico/Rexall Sundown Eyes Private Label As Key Growth Area

Combined Royal Numico/Rexall Sundown operations regard their potential for private label sales in the U.S. mass market to be "very high," the firms reported during a May 1 teleconference. Numico and Rexall have little presence in U.S. private label now but appear to be pondering it for the future despite the traditional low margins of the products.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts